LEQVIO

Google image searchProduct monograph

Active ingredient

inclisiran (inclisiran sodium), 284 MG/1.5 ML

DIN: 02518376

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Schedule: Prescription

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 26-SEP-2022

ATC:

• C10 — LIPID MODIFYING AGENTS (ATC, ATC/DDD, )
• C10A — LIPID MODIFYING AGENTS, PLAIN (ATC, ATC/DDD)
• C10AX — Other lipid modifying agents (ATC, ATC/DDD)
• C10AX16 — INCLISIRAN (ATC/DDD)

Reference brand drug: Leqvio

External Links for Leqvio

Search on Google

• Leqvio side effects
• Leqvio dosage
• inclisiran side effects
• inclisiran dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find leqvio photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.